REGENERATIVE RESEARCH FOUNDATION (EIN 203654626) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

WILLIAM KAHN CPA

Phone

5186948188

Tax Period

2024-01-01 to 2024-12-31

REGENERATIVE RESEARCH FOUNDATION, founded in 2005, is a community nonprofit in the Medical Research sector that reported $7.0M in total revenue in fiscal year 2024. Revenue fell 20% from the prior year — a significant decline worth monitoring. Expenses of $6.5M left a modest 7% surplus.

Mission

THE PRINCIPAL MISSION OF THE REGENERATIVE RESEARCH FOUNDATION IS TO DEVELOP REGENERATIVE STEM CELL THERAPIES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS): THE BRAIN, SPINAL CORD, AND RETINA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $5,982,290

Program Service Revenue $782,345

Investment Income $75,008

Other Revenue $166,895

TOTAL REVENUE $7,006,538

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,003,454

Fundraising Expenses $0

Program Expenses $5,188,569

Other Expenses $3,487,594

TOTAL EXPENSES $6,491,048

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,006,538	$8,795,245	-0.2%
Expenses	$6,491,048	$7,305,106	-0.1%
Net Income	$515,490	$1,490,139	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$249,374

Total Directors

$53,535

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM KAHN CPA	CHAIR	5.00	Officer Director	$0	$0	$0
JEFFREY H STERN MD PHD	DIRECTOR FOR TRANSLATIONAL	30.00	Officer Director	$53,025	$510	$53,535
JOHN WALSH	DIRECTOR	1.00	Director	$0	$0	$0
VITO GRASSO MPA CAE	DIRECTOR	1.00	Director	$0	$0	$0
DAVID O CARPENTER MD	DIRECTOR	1.00	Director	$0	$0	$0
DAWN ABBUHL	DIRECTOR	1.00	Director	$0	$0	$0
ROBERT CATALANO MD	DIRECTOR	1.00	Director	$0	$0	$0
AMY G KLANN PHD JD	DIRECTOR	1.00	Director	$0	$0	$0
SALLY TEMPLE-STERN PHD	SCIENTIFIC & EXECUTIVE DIR	65.00	Officer	$173,942	$21,897	$195,839
CAITLIN HILL	PRINCIPAL INVESTIGATOR	40.00	Highest	$135,055	$6,756	$141,811
THOMAS KIEHL	PRINCIPAL INVESTIGATOR	40.00	Highest	$131,200	$14,982	$146,182
GLENNA FORD	CLINICAL TRIAL MANAGER	40.00	Highest	$139,694	$15,319	$155,013
DAVID BUTLER PHD	PRINCIPAL INVESTIGATOR	60.00	Highest	$101,541	$5,314	$106,855

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,006,538	$6,491,048	$9,028,494	$515,490
2023	$8,795,245	$7,305,106	$6,996,425	$1,490,139
2022	$7,532,149	$5,849,247	$5,981,949	$1,682,902
2021	$5,099,449	$4,611,189	$4,518,761	$488,260
2020	$3,574,825	$3,718,838	$2,551,269	$-144,013
2019	$3,531,037	$3,699,830	$2,293,624	$-168,793
2018	$3,248,836	$3,843,206	$2,574,291	$-594,370

REGENERATIVE RESEARCH FOUNDATION